Lonza Group Ag Free Cash Flow Per Share 2012-2024 | LZAGY

Current and historical free cash flow per share for Lonza Group Ag (LZAGY) from 2012 to 2024. Free cash flow per share can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis Lonza Group Ag free cash flow per share for the three months ending December 31, 2024 was $0.00.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $49.121B $7.468B
Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $229.693B 27.62
Boston Scientific (BSX) United States $154.617B 38.71
Stryker (SYK) United States $145.191B 30.36
EssilorLuxottica (ESLOY) France $128.660B 0.00
Medtronic (MDT) Ireland $104.194B 14.77
Haleon (HLN) United Kingdom $50.678B 28.85
ResMed (RMD) United States $35.889B 26.96
GE HealthCare Technologies (GEHC) United States $32.579B 15.47
Agilent Technologies (A) United States $31.612B 20.53
Terumo (TRUMY) Japan $27.743B 36.03
Insulet (PODD) United States $22.770B 89.38
Koninklijke Philips (PHG) Netherlands $21.553B 15.49
Zimmer Biomet Holdings (ZBH) United States $18.259B 11.73
Baxter (BAX) United States $15.693B 11.72
Smith & Nephew SNATS (SNN) United Kingdom $12.530B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.236B 21.70
Lantheus Holdings (LNTH) United States $5.132B 12.95
Prestige Consumer Healthcare (PBH) United States $4.168B 18.62
Perrigo (PRGO) Ireland $3.726B 9.44
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.248B 14.79
ICU Medical (ICUI) United States $3.162B 23.32
Envista Holdings (NVST) United States $3.141B 26.10
GN Store Nord (GNNDY) Denmark $2.200B 18.22
QuidelOrtho (QDEL) United States $2.144B 14.74
LeMaitre Vascular (LMAT) United States $1.830B 40.91
AtriCure (ATRC) United States $1.660B 0.00
Acuren (TIC) United States $1.336B 0.00
Neogen (NEOG) United States $1.326B 16.97
AdaptHealth (AHCO) United States $1.225B 12.44
Kestra Medical Technologies (KMTS) United States $1.174B 0.00
Green Thumb Industries (GTBIF) United States $1.103B 24.81
BioLife Solutions (BLFS) United States $1.062B 0.00
Phibro Animal Health (PAHC) United States $0.993B 12.69
InMode (INMD) Israel $0.910B 9.17
CeriBell (CBLL) United States $0.621B 0.00
Evolus (EOLS) United States $0.600B 0.00
Curaleaf Holdings (CURLF) Canada $0.593B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.563B 0.00
Valneva SE (VALN) France $0.533B 0.00
Owens & Minor (OMI) United States $0.504B 4.18
Capricor Therapeutics (CAPR) United States $0.486B 0.00
Tilray Brands (TLRY) Canada $0.453B 0.00
Surmodics (SRDX) United States $0.418B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.366B 0.00
SNDL (SNDL) Canada $0.342B 0.00
Cresco Labs (CRLBF) United States $0.329B 0.00
Canopy Growth (CGC) Canada $0.325B 0.00
VAREX IMAGING (VREX) United States $0.324B 11.91
Aurora Cannabis (ACB) Canada $0.310B 55.20
Viemed Healthcare (VMD) United States $0.260B 21.90
Sanara MedTech (SMTI) United States $0.257B 0.00
ZimVie (ZIMV) United States $0.245B 11.14
Cerus (CERS) United States $0.242B 0.00
Verano Holdings (VRNOF) United States $0.240B 0.00
Sanuwave Health (SNWV) United States $0.236B 0.00
TriSalus Life Sciences (TLSI) United States $0.211B 0.00
OraSure Technologies (OSUR) United States $0.207B 0.00
Quanterix (QTRX) United States $0.205B 0.00
Brainsway (BWAY) Israel $0.202B 53.50
Biote (BTMD) United States $0.193B 5.43
Omeros (OMER) United States $0.184B 0.00
Organigram Global (OGI) Canada $0.181B 0.00
High Tide (HITI) Canada $0.181B 0.00
Utah Medical Products (UTMD) United States $0.176B 14.30
Exagen (XGN) United States $0.143B 0.00
FitLife Brands (FTLF) United States $0.135B 16.62
Jin Medical (ZJYL) China $0.119B 0.00
TerrAscend (TSNDF) Canada $0.119B 0.00
Agape ATP (ATPC) $0.093B 0.00
Fonar (FONR) United States $0.089B 11.48
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
MacroGenics (MGNX) United States $0.088B 0.00
Veru (VERU) United States $0.077B 0.00
Quipt Home Medical (QIPT) United States $0.076B 0.00
Zynex (ZYXI) United States $0.075B 0.00
InterCure (INCR) Israel $0.070B 0.00
Apyx Medical (APYX) United States $0.063B 0.00
Jushi Holdings (JUSHF) United States $0.060B 0.00
ImmuCell (ICCC) United States $0.056B 0.00
Cytosorbents (CTSO) United States $0.053B 0.00
United Health Products (UEEC) United States $0.052B 0.00
Modular Medical (MODD) United States $0.047B 0.00
United-Guardian (UG) United States $0.039B 13.45
Rockwell Medical (RMTI) United States $0.033B 0.00
Nephros (NEPH) United States $0.031B 41.74
Safety Shot (SHOT) United States $0.026B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
INLIF (INLF) $0.019B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00